J&J Gets Second Chance At Sedasys Sedation Device Approval

Johnson & Johnson subsidiary Ethicon Endo-Surgery has received a go-ahead from the FDA commissioner's office to embark on a rarely used process to appeal a PMA denial by the agency’s device center.

More from Archive

More from Medtech Insight